Literature DB >> 7793496

The learning curve for laparoscopic cholecystectomy. The Southern Surgeons Club.

M J Moore1, C L Bennett.   

Abstract

BACKGROUND: The use of laparoscopic surgical procedures without previous training has grown rapidly. At the same time, there have been allegations of increased complications among less experienced surgeons.
METHODS: Using multivariate regression analyses, we evaluated the relationship between bile duct injury rate and experience with laparoscopic cholecystectomy for surgeons in the Southern Surgeons Club.
RESULTS: Fifty-five surgeons performed 8,839 procedures. Fifteen bile duct injuries (by 13 surgeons) resulted with 90% of the injuries occurring within the first 30 cases performed by an individual surgeon. Multivariate analyses indicated that the only significant factor associated with an adverse outcome was the surgeon's experience with the procedure. A regression model predicted that a surgeon had a 1.7% chance of a bile duct injury occurring in the first case and a 0.17% chance of a bile duct injury at the 50th case.
CONCLUSIONS: While surgeons appear to learn this procedure rapidly, institutions might consider requiring surgeons to move beyond the initial learning curve before awarding privileges.

Entities:  

Mesh:

Year:  1995        PMID: 7793496     DOI: 10.1016/s0002-9610(99)80252-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  94 in total

1.  Laparoscopic cholecystectomy in routine practice: duct injury as an index event.

Authors:  T F Gorey; P Papasavas
Journal:  Ir J Med Sci       Date:  1999 Jul-Sep       Impact factor: 1.568

Review 2.  Improving continuing medical education for surgical techniques: applying the lessons learned in the first decade of minimal access surgery.

Authors:  D A Rogers; A S Elstein; G Bordage
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

3.  Virtual reality training improves operating room performance: results of a randomized, double-blinded study.

Authors:  Neal E Seymour; Anthony G Gallagher; Sanziana A Roman; Michael K O'Brien; Vipin K Bansal; Dana K Andersen; Richard M Satava
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

4.  Robotic surgery: identifying the learning curve through objective measurement of skill.

Authors:  L Chang; R M Satava; C A Pellegrini; M N Sinanan
Journal:  Surg Endosc       Date:  2003-09-10       Impact factor: 4.584

Review 5.  Laparoscopic cholecystectomy: early and late complications and their treatment.

Authors:  A Shamiyeh; W Wayand
Journal:  Langenbecks Arch Surg       Date:  2004-05-05       Impact factor: 3.445

6.  Development and evaluation of a simulator-based laparoscopic training program for surgical novices.

Authors:  Emmeline Nugent; Nicole Shirilla; Adnan Hafeez; Diarmuid S O'Riordain; Oscar Traynor; Anthony M Harrison; Paul Neary
Journal:  Surg Endosc       Date:  2012-07-07       Impact factor: 4.584

Review 7.  Review of available methods of simulation training to facilitate surgical education.

Authors:  Badma Bashankaev; Sergey Baido; Steven D Wexner
Journal:  Surg Endosc       Date:  2010-06-15       Impact factor: 4.584

8.  A safe laparoscopic cholecystectomy depends upon the establishment of a critical view of safety.

Authors:  Yuichi Yamashita; Taizo Kimura; Sumio Matsumoto
Journal:  Surg Today       Date:  2010-05-23       Impact factor: 2.549

9.  Single-incision laparoscopic surgery (SILS™) versus standard laparoscopic surgery: a comparison of performance using a surgical simulator.

Authors:  Byron F Santos; Daniel Enter; Nathaniel J Soper; Eric S Hungness
Journal:  Surg Endosc       Date:  2010-06-29       Impact factor: 4.584

10.  The NOVEL trial: natural orifice versus laparoscopic cholecystectomy-a prospective, randomized evaluation.

Authors:  Steven D Schwaitzberg; Kurt Roberts; John R Romanelli; David J Desilets; David Earle; Santiago Horgan; Lee Swanstrom; Eric Hungness; Nathaniel Soper; Michael L Kochman
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.